Bullish & Foolish
Full AMIX fundamentals All 466 on the Survival Watch

AMIXAutonomix Medical, Inc.

Is Autonomix Medical struggling financially?

Yes, by its own account. Autonomix Medical told the SEC on 27 May 2026, in Form 10-K, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$5.1M
Source filing
10-K 27 May 2026
Balance sheet
30 Jun 2026

Cash runway

  • 2months

    If the burn speeds up

    Empty by Aug 2026

  • 4months

    If it eases off

    Empty by Oct 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$3.5M

÷

Cash burned over the last 12 months

$12.3M

What Autonomix Medical told the SEC

…Form 10-K and our other filings with the SEC, before making an investment decision in our securities. Risks Related to Our Overall Business Factors raise substantial doubt about our ability to continue as a going concern; We have no approved products, and we cannot assure you that we will generate revenue or become profitable in the future; We will need additional financing over the longer term to…

Autonomix Medical, Inc., Form 10-K, filed 27 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • Cash burn is narrowing It is spending 39% less cash per year than it was, so the runway above is lengthening rather than shortening.

Other Biotech/Pharma companies that filed the doubt